The Rheumatologist
COVID-19 NewsACR Convergence
You are here: Home / Articles / What Rheumatologists Should Know About Childhood-Onset SLE & Vasculitis

What Rheumatologists Should Know About Childhood-Onset SLE & Vasculitis

• By

Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

References

  1. Hunder GG. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med. 1998 Sep 1;129(5):417–418 Annals of Internal Medicine 1998.
  2. Brogan PA, Arch B, Hickey H, et al. Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: An open-label, randomized, bayesian noninferiority trial. Arthritis Rheumatol. 2021 Sep;73(9):1673–1682.

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »